Your browser is no longer supported. Please, upgrade your browser.
Settings
COO [NYSE]
The Cooper Companies, Inc.
IndexS&P 500 P/E8.84 EPS (ttm)45.26 Insider Own0.30% Shs Outstand49.10M Perf Week4.98%
Market Cap19.40B Forward P/E27.70 EPS next Y14.44 Insider Trans-36.15% Shs Float48.86M Perf Month4.66%
Income2.25B PEG0.88 EPS next Q3.04 Inst Own98.90% Short Float2.57% Perf Quarter4.78%
Sales2.47B P/S7.87 EPS this Y-47.90% Inst Trans-0.60% Short Ratio4.44 Perf Half Y12.28%
Book/sh121.99 P/B3.28 EPS next Y10.73% ROA31.10% Target Price406.45 Perf Year33.91%
Cash/sh2.46 P/C162.92 EPS next 5Y10.00% ROE52.30% 52W Range268.92 - 401.92 Perf YTD10.10%
Dividend0.06 P/FCF94.29 EPS past 5Y3.00% ROI5.10% 52W High-0.57% Beta0.81
Dividend %0.01% Quick Ratio0.80 Sales past 5Y6.20% Gross Margin63.20% 52W Low48.60% ATR7.19
Employees12000 Current Ratio1.30 Sales Q/Q5.30% Oper. Margin13.60% RSI (14)65.47 Volatility1.59% 1.75%
OptionableYes Debt/Eq0.30 EPS Q/Q2221.70% Profit Margin91.20% Rel Volume1.04 Prev Close400.00
ShortableYes LT Debt/Eq0.24 EarningsMar 04 AMC Payout0.10% Avg Volume282.95K Price399.62
Recom2.30 SMA203.60% SMA503.80% SMA20015.96% Volume176,843 Change-0.10%
Jul-06-20Downgrade Robert W. Baird Outperform → Neutral $291
Mar-05-20Initiated Citigroup Neutral $360
Feb-01-19Upgrade Stephens Equal-Weight → Overweight $305
Jan-04-19Downgrade Goldman Neutral → Sell
Jul-30-18Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
Apr-04-18Initiated Goldman Neutral $231
Dec-08-17Reiterated Stifel Buy $275 → $265
Sep-12-17Reiterated Stifel Buy $265 → $275
Sep-01-17Reiterated Piper Jaffray Overweight $265 → $280
Jul-21-17Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Jun-29-17Initiated Guggenheim Neutral
Jun-02-17Reiterated Stifel Buy $220 → $231
Dec-12-16Upgrade Wells Fargo Market Perform → Outperform
Sep-02-16Reiterated BMO Capital Markets Outperform $199 → $206
Aug-31-16Reiterated Stifel Buy $195 → $215
Jun-30-16Reiterated Stifel Buy $180 → $195
Jun-03-16Reiterated Jefferies Buy $175 → $190
Apr-15-16Upgrade Jefferies Hold → Buy
Dec-17-15Initiated Goldman Neutral
Dec-04-15Downgrade JP Morgan Overweight → Neutral
Apr-14-21 05:02PM  
Apr-06-21 06:51PM  
Apr-02-21 08:00AM  
Mar-31-21 01:24PM  
Mar-25-21 04:49PM  
02:50PM  
12:00PM  
Mar-24-21 04:15PM  
Mar-22-21 06:19PM  
Mar-18-21 08:30AM  
08:00AM  
Mar-17-21 01:32PM  
08:33AM  
Mar-14-21 04:08PM  
Mar-11-21 12:53PM  
Mar-10-21 11:16PM  
Mar-08-21 06:02AM  
Mar-06-21 02:10AM  
Mar-05-21 12:04PM  
09:04AM  
09:00AM  
04:58AM  
01:01AM  
Mar-04-21 05:35PM  
04:45PM  
04:15PM  
03:15PM  
Mar-03-21 10:38AM  
Mar-02-21 04:15PM  
09:39AM  
Mar-01-21 04:15PM  
Feb-22-21 02:45PM  
Feb-18-21 04:15PM  
Feb-08-21 08:43AM  
Feb-05-21 09:55AM  
Feb-04-21 04:15PM  
Feb-03-21 04:20PM  
12:10PM  
11:23AM  
Feb-02-21 10:00AM  
Jan-26-21 04:15PM  
Jan-17-21 02:18AM  
Jan-08-21 10:00AM  
Jan-07-21 04:15PM  
Dec-28-20 08:52AM  
Dec-22-20 12:45AM  
Dec-21-20 04:15PM  
02:22PM  
Dec-17-20 04:15PM  
Dec-10-20 04:15PM  
Dec-04-20 08:45AM  
Dec-03-20 11:00PM  
05:35PM  
04:32PM  
04:15PM  
03:15PM  
Dec-02-20 10:10AM  
Nov-29-20 03:00PM  
Nov-26-20 12:30PM  
08:58AM  
12:06AM  
Nov-24-20 08:21AM  
Nov-12-20 04:15PM  
Nov-10-20 09:23AM  
08:00AM  
Nov-03-20 04:15PM  
Oct-27-20 07:59AM  
Oct-19-20 02:11PM  
Oct-09-20 08:00AM  
Oct-03-20 11:30AM  
Oct-01-20 07:50AM  
Sep-21-20 03:02PM  
06:47AM  
Sep-14-20 10:02AM  
Sep-12-20 07:28AM  
Sep-10-20 07:15AM  
Sep-08-20 08:33AM  
Sep-07-20 02:03AM  
Sep-05-20 10:50AM  
Sep-04-20 03:50PM  
07:29AM  
06:31AM  
Sep-03-20 05:11PM  
04:15PM  
Sep-02-20 10:13AM  
Aug-31-20 04:15PM  
03:01PM  
08:15AM  
Aug-26-20 12:30PM  
Aug-24-20 11:20AM  
Aug-19-20 04:15PM  
Aug-13-20 04:15PM  
Aug-06-20 04:15PM  
Aug-05-20 11:40AM  
Jul-20-20 04:02PM  
Jul-11-20 03:46PM  
Jul-09-20 04:15PM  
Jul-06-20 04:15PM  
Jul-02-20 09:34AM  
Jun-30-20 12:56PM  
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, eye care practitioners, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in San Ramon, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffApr 15Option Exercise153.461,854284,5142,709Apr 15 06:37 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffApr 15Sale397.922,6431,051,6991,088Apr 15 06:37 PM
WEISS ROBERT SDirectorApr 01Option Exercise0.00989063,798Apr 05 04:57 PM
PETERSMEYER GARY SDirectorApr 01Option Exercise0.0098902,327Apr 05 04:56 PM
MADDEN TERESA SDirectorApr 01Option Exercise0.002690356Apr 05 04:53 PM
Lindell Jody SDirectorApr 01Option Exercise0.00989013,543Apr 05 04:52 PM
KOZY WILLIAM ADirectorApr 01Option Exercise0.0098904,917Apr 05 04:50 PM
Jay ColleenDirectorApr 01Option Exercise0.0098904,647Apr 05 04:47 PM
White Albert G IIIPresident & CEOMar 08Option Exercise128.6679,74510,259,985121,175Mar 08 06:32 PM
White Albert G IIIPresident & CEOMar 08Sale388.6279,74530,990,53341,430Mar 08 06:32 PM
Auerbach Robert DSpecial Advisor to the CEOFeb 01Option Exercise0.0059203,049Feb 02 06:18 PM
Auerbach Robert DSpecial Advisor to the CEOJan 08Option Exercise0.002,10902,847Jan 12 05:04 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffJan 08Option Exercise0.0087102,538Jan 12 05:02 PM
Drury Mark JVP, General Counsel & Sec.Jan 08Option Exercise0.001,12701,535Jan 12 04:58 PM
Andrews Brian GEVP, CFO & TreasurerJan 08Option Exercise0.0044201,961Jan 12 04:55 PM
Sheffield Holly RPresident, CSIJan 08Option Exercise0.0058901,874Jan 12 04:53 PM
Auerbach Robert DSpecial Advisor to the CEOOct 08Sale350.002,538888,3001,403Oct 09 08:26 PM
PETERSMEYER GARY SDirectorOct 06Option Exercise162.691,000162,6902,338Oct 07 05:06 PM
PETERSMEYER GARY SDirectorOct 06Sale348.541,000348,5401,338Oct 07 05:06 PM
Lindell Jody SDirectorSep 16Option Exercise66.806,500434,20019,054Sep 17 05:21 PM
Lindell Jody SDirectorSep 16Sale338.696,5002,201,45312,554Sep 17 05:21 PM
White Albert G IIIPresident & CEOJul 08Buy278.231,000278,23041,430Jul 08 04:58 PM
Sheffield Holly REVP, CSOJul 08Buy280.19534149,6241,414Jul 08 04:57 PM
Sheffield Holly REVP, CSOJul 08Buy280.0035599,4001,285Jul 08 04:57 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffJul 01Option Exercise0.0034802,148Jul 02 05:45 PM
Sheffield Holly REVP, CSOJun 12Buy283.18880249,198880Jun 15 04:43 PM
Ricupati AgostinoSVP, Fin & Tax; Chief Actg OffJun 11Buy281.471,000281,4701,800Jun 15 04:39 PM
Sheffield Holly REVP, CSOJun 04Option Exercise0.001,10501,383Jun 08 04:30 PM